In the OVE26 mouse model of type 1 diabetes, it was shown that RAGE deficiency reduced glomerulosclerosis, improved renal function and this was accompanied by decreased MG and increased GLO1 expression (Reiniger et al. 2010). Here, GLO1 is linked to myasthenia gravis.